Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: ams, low urine output major surgical or invasive procedure: : s/p right knee replacement history of present illness: 74 yo male with h/o dm2, htn, cad with stent placement, one kidney, parkinson's dz. end-stage tricompartmental oa, presented for right tkr. after surgery, patient was somnolent and with low urine output. in or/pacu patient received 4l liters fluids + 500 cc 5% albumin, with uop 376cc (10-20 cc/hr). patient developed increasing somnolence throughout the day. received total 1.5mg dilaudid per pca in pacu. he also received 1g tylenol and 4u insulin sc. creatinine was 1.3 (baseline 1.0-1.2). hematocrit 25 at 5pm, subsequently 23 (baseline 30-33). abg 7.42/44/64/30. vitals in pacu: t 96.8-97.4 hr 50-100 bp 120s/50s rr 15-20 o2sa 98-99% on 2l vitals on arrival to the micu: t 100.1 hr 102 bp 141/62 rr 22 sao2 96% on 2l nc upon transfer to the micu he was transfused 1u rbc followed by 20mg lasix, after which uop rose to ~100cc/hr. past medical history: 1)3vcad - s/p stemi and ptca of lad at - s/p ptca & des to om1 - s/p des to prox/mid-lad & om1 - s/p stent & balloon angioplasty to lad - ecg : notable for sr, pr 214, poor r wave progression, nonspecific lateral lead st-t wave abnormalities 2)hypertension 3)dyslipidemia 4)bph 5)type 2 diabetes with peripheral neuropathy 6)s/p r nephrectomy ~10 years ago at - path benign per patient 7)parkinson's disease: - diagnosed age 70 - followed as outpatient by dr. . - carbidopa/levodopa 8)bells' palsy ( htn) s/p valtrex 9)ckd stage ii baseline 1.0-1.2 10)depression 11)microcytic anemia-stable all his life-?thalassemia. neg, -egd in past 12)elevated psa 13)urinary frequency and incomplete emptying on uds 14)knee arthritis social history: lives with his wife and son. retired at . no smoking, drinking or illicit drug use. does work part-time now at a gun and rifle club. notes that his diet is not good --> pizza, sandwiches. family history: no family history of early mi, arrhythmia, cardiomyopathies, or sudden cardiac death. physical exam: well appearing in no acute distress afebrile with stable vital signs pain well-controlled respiratory: ctab cardiovascular: rrr gastrointestinal: nt/nd genitourinary: foley catheter, remove at 6am neurologic: intact with no focal deficits psychiatric: pleasant, a&o x3 musculoskeletal lower extremity: * incision healing well with staples * sanguinous drainage from proximal wound, dressed with silver nitrate and steristrips placed on , good effect * eccymosis medial/lateral knee and shin * thigh full but soft * no calf tenderness * silt, nvi distally * toes warm * +cap refill * weak pt, -at pertinent results: cxr : low lung volumes. interval appearance of mild interstitial edema and engorged pulmonary vasculature. heart size is increased. bibasilar opacities likely atelectasis. stomach is distended with gas. 07:30am blood wbc-9.9 rbc-3.66* hgb-9.2* hct-28.6* mcv-78* mch-25.1* mchc-32.1 rdw-17.6* plt ct-331 07:05am blood wbc-8.6 rbc-3.62* hgb-9.5* hct-28.2* mcv-78* mch-26.3* mchc-33.7 rdw-16.9* plt ct-268 01:00am blood wbc-8.4 rbc-3.53* hgb-9.3*# hct-27.0* mcv-76* mch-26.2* mchc-34.3 rdw-16.9* plt ct-262 05:30am blood wbc-6.6 rbc-2.99* hgb-7.3* hct-22.6* mcv-76* mch-24.4* mchc-32.2 rdw-16.9* plt ct-205 08:00am blood wbc-7.8 rbc-3.26* hgb-7.9* hct-24.3* mcv-75* mch-24.2* mchc-32.4 rdw-16.8* plt ct-187 08:00am blood wbc-8.4 rbc-3.54* hgb-8.8* hct-26.4* mcv-75* mch-24.8* mchc-33.2 rdw-16.6* plt ct-145* 07:55am blood wbc-10.0 rbc-3.36* hgb-7.9* hct-24.5* mcv-73* mch-23.4* mchc-32.2 rdw-16.6* plt ct-116* 07:35am blood wbc-11.7* rbc-3.60* hgb-8.3* hct-25.5* mcv-71* mch-23.2* mchc-32.7 rdw-15.3 plt ct-130* 03:22am blood wbc-9.6 rbc-4.06* hgb-9.4* hct-28.8* mcv-71* mch-23.1* mchc-32.6 rdw-15.6* plt ct-119* 05:30pm blood wbc-9.8 rbc-3.58*# hgb-7.9*# hct-25.2*# mcv-70* mch-22.0* mchc-31.4 rdw-15.7* plt ct-145* 05:30pm blood neuts-78.4* lymphs-15.8* monos-5.0 eos-0.5 baso-0.3 07:05am blood pt-11.5 inr(pt)-1.1 07:30am blood glucose-184* urean-23* creat-0.9 na-133 k-4.2 cl-98 hco3-26 angap-13 07:05am blood glucose-204* urean-28* creat-0.9 na-134 k-3.9 cl-97 hco3-27 angap-14 05:30am blood glucose-168* urean-33* creat-1.1 na-134 k-3.6 cl-98 hco3-26 angap-14 07:05am blood calcium-8.1* phos-2.5* mg-2.0 05:30am blood calcium-7.7* phos-2.5* mg-2.3 08:00am blood calcium-7.8* phos-2.4* mg-2.4 07:37pm blood type-art o2 flow-2 po2-64* pco2-44 ph-7.42 caltco2-30 base xs-3 intubat-not intuba 07:37pm blood hgb-7.8* calchct-23 o2 sat-91 brief hospital course: the patient was admitted to the orthopaedic surgery service and was taken to the operating room for above described procedure. please see separately dictated operative report for details. the surgery was uncomplicated and the patient tolerated the procedure well. patient received perioperative iv antibiotics. postoperative course was remarkable for the following: 1. admit to for post op medical management. course as below. transferred to the floor late in the evening on pod1 2. geriatric c/s for medical co-management 3. post-op anemia - pod2 hct 25.5 -> 1u prbc, pod3 hct 24.5, asymptomatic -> transfused additional 1u prbcs. pod5 hct 24.3 -> 1u prbcs, pod6 -> hct 22.6 -> 2u prbcs 4. neuro consult for r foot motor deficit - incomplete study, but no obvious nerve compression. 5. hematuria and urinary retention - started on bactrim prophylactically. hematura cleared spontaneously. patient was unable to void, straight cathed x many, when urine culture confirmed negative, stopped bactrim and foley placed . foley removed at 6am but patient failed voising trial, bladder scanned > 400cc after 6 hrs. foley replaced, increased terazosin 15mg daily, repeat voiding trial at 6am. otherwise, pain was initially controlled with iv pain meds followed by a transition to oral pain medications on pod#1. the patient received lovenox for dvt prophylaxis starting on the morning of pod#1. the surgical dressing was changed on pod#2 and the surgical incision was found to be clean and intact without erythema or abnormal drainage. the patient was seen daily by physical therapy. labs were checked throughout the hospital course and repleted accordingly. at the time of discharge the patient was tolerating a regular diet and feeling well. the patient was afebrile with stable vital signs. the patient's hematocrit was acceptable and pain was adequately controlled on an oral regimen. the operative extremity was neurovascularly intact and the wound was benign. the patient's weight-bearing status is weight bearing as tolerated on the operative extremity. mr. is discharged to rehab in stable condition. : 74m with dm, htn, cad, parkinson's s/p r tkr experienced low uop and ams in pacu and transferred to micu. ams likely secondary to narcotics, low urine output secondary to under-rescuscitation. acute issues: # anemia: received 4l crystalloid + 0.5l colloid in the or during the procedure. he also received 1 unit prbcs. he was given another 1 un prbcs with lasix upon arrival to the icu. his hct responded appropriately with an increase from 25.2 to 28.8. # ams: pt was very somnolent on arrival but was arousable. attributed to a combination of narcotics and underlying parkinson's disease. the patient had no focal neurologic deficits so further imaging of the head was not obtained. he became significantly more interactive throughout his course and on transfer was at baseline. # cad/hyperlipidemia: requires antiplatelet therapy s/p stents. the patient's and were restarted after consulting with orthopedics. # s/p tkr: patient was in repositiong device during stay. started on lovenox for dvt prophylaxis. stable issues: # /low uop: cr on admission was slightly higher than baseline (1.3 vs 1.0-1.2). the patient is s/p nephrectomy, which combined with intraop blood loss probably contributed to his . urine output responded to lasix # dm2: patient was placed back on home insulin at 40 units of 70/30 and sliding scale. sugars remained well controlled. # htn: sbps were up to 160s in micu. the patient was restarted on home metoprolol dose. his home valsartan and hctz were held pending followup creatinine. cr remained stable at 1.3 at the time of transfer. # parkinson's: stable. continued on home carbidopa-levodopa. # bph: stable, home finasteride and terazosin continued. transitional issues: f/u outpatient as per ortho. medications on admission: , diovan, hctz, insulin, carbidopa, levodopa, finasteride, mirtazapine, clopidogrel, pravachol, hytrin, metoprolol discharge medications: 1. carbidopa-levodopa 25-100 mg tablet sig: two (2) tablet po tid (3 times a day). 2. pravastatin 40 mg tablet sig: one (1) tablet po once a day. 3. metoprolol succinate 100 mg tablet extended release 24 hr sig: one (1) tablet extended release 24 hr po once a day. 4. clopidogrel 75 mg tablet sig: one (1) tablet po once a day. 5. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po once a day. 6. acetaminophen 500 mg tablet sig: two (2) tablet po q8h (every 8 hours) as needed for pain. 7. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 8. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day). 9. bisacodyl 10 mg suppository sig: one (1) suppository rectal hs (at bedtime) as needed for constipation. 10. finasteride 5 mg tablet sig: one (1) tablet po once a day. 11. mirtazapine 7.5 mg tablet sig: one (1) tablet po at bedtime as needed for insomnia. 12. polyethylene glycol 3350 17 gram powder in packet sig: one (1) powder in packet po once a day as needed for constipation. 13. enoxaparin 40 mg/0.4 ml syringe sig: one (1) syringe subcutaneous once a day for 4 weeks: restart: last dose: . 14. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po once a day: resume 325mg daily after lovenox completed. 15. oxycodone 5 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for pain: hold for sedation or confusion. disp:*50 tablet(s)* refills:*0* 16. insulin nph & regular human 100 unit/ml (70-30) suspension sig: forty (40) units subcutaneous twice a day: home dose, but has been held while inpatient poor appetite. 17. terazosin 5 mg capsule sig: three (3) capsule po hs (at bedtime): dose increased from 10mg daily urinary retention. discharge disposition: extended care facility: - discharge diagnosis: right knee osteoarthritis urinary retention post-op anemia due to blood loss discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: out of bed with assistance to chair or wheelchair. discharge instructions: 1. please return to the emergency department or notify your physician if you experience any of the following: severe pain not relieved by medication, increased swelling, decreased sensation, difficulty with movement, fevers greater than 101.5, shaking chills, increasing redness or drainage from the incision site, chest pain, shortness of breath or any other concerns. 2. please follow up with your primary physician regarding this admission and any new medications and refills. 3. resume your home medications unless otherwise instructed. 4. you have been given medications for pain control. please do not drive, operate heavy machinery, or drink alcohol while taking these medications. as your pain decreases, take fewer tablets and increase the time between doses. this medication can cause constipation, so you should drink plenty of water daily and take a stool softener (such as colace) as needed to prevent this side effect. call your surgeons office 3 days before you are out of medication so that it can be refilled. these medications cannot be called into your pharmacy and must be picked up in the clinic or mailed to your house. please allow an extra 2 days if you would like your medication mailed to your home. 5. you may not drive a car until cleared to do so by your surgeon. 6. please keep your wounds clean. you may shower starting five (5) days after surgery, but no tub baths or swimming for at least four (4) weeks. no dressing is needed if wound continues to be non-draining. any stitches or staples that need to be removed will be taken out at your follow-up visit in three (3) weeks after your surgery. 7. please call your surgeon's office to schedule or confirm your follow-up appointment in three (3) weeks. 8. please do not take any non-steroidal anti-inflammatory medications (nsaids such as celebrex, ibuprofen, advil, aleve, motrin, etc). 9. anticoagulation: please continue your lovenox for four (4) weeks to help prevent deep vein thrombosis (blood clots). if you were taking aspirin prior to your surgery, it is ok to continue at your previous dose while taking this medication. stockings x 6 weeks. 10. wound care: please keep your incision clean and dry. it is okay to shower five days after surgery but no tub baths, swimming, or submerging your incision until after your four (4) week checkup. please place a dry sterile dressing on the wound each day if there is drainage, otherwise leave it open to air. check wound regularly for signs of infection such as redness or thick yellow drainage. staples will be removed at your follow-up visit in three (3) weeks. 11. vna (once at home): home pt/ot, dressing changes as instructed, and wound checks. 12. activity: weight bearing as tolerated on the operative extremity. mobilize. cpm/rom as tolerated. no strenuous exercise or heavy lifting until follow up appointment. left foot afo at all times when ambulating. physical therapy: rle wbat intensive rom cpm 2-3x/day for 2hr sessions, maximum flexion as tolerated left foot afo aat when ambulating mobilize frequently treatments frequency: dry sterile dressing daily as needed for drainage wound checks ice and elevation teds d/c foley catheter at 6am and repeat voiding trial *staples will be removed at follow-up appointment in 3 weeks* followup instructions: provider: , : date/time: 3:00 provider: , m.d. phone: date/time: 4:00 provider: , md phone: date/time: 4:00 procedure: total knee replacement diagnoses: thrombocytopenia, unspecified coronary atherosclerosis of native coronary artery congestive heart failure, unspecified acute posthemorrhagic anemia acute kidney failure, unspecified hyposmolality and/or hyponatremia acute on chronic diastolic heart failure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes depressive disorder, not elsewhere classified other opiates and related narcotics causing adverse effects in therapeutic use percutaneous transluminal coronary angioplasty status hypopotassemia other and unspecified hyperlipidemia hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) paralysis agitans hemorrhage complicating a procedure long-term (current) use of insulin old myocardial infarction retention of urine, unspecified iron deficiency anemia, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation anticoagulants causing adverse effects in therapeutic use urinary complications, not elsewhere classified drug-induced delirium acquired absence of kidney hematuria, unspecified delirium due to conditions classified elsewhere insomnia, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage i through stage iv, or unspecified long-term (current) use of aspirin chronic kidney disease, stage ii (mild) osteoarthrosis, localized, not specified whether primary or secondary, lower leg other symptoms involving nervous and musculoskeletal systems 

Answer: The patient is high likely exposed to